Arca
Skip to content

ColActive Plus

Wound Dressing With Animal-Derived Material(S). 510(k) K260652, from Covalon Technologies, Ltd. (Mississauga, CA). Product code KGN, class U.

As of Nov 18, 2026, K260652 is an FDA 510(k) held by Covalon Technologies, Ltd., substantially equivalent on Sep 9, 2026 after 194 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Sep 9, 2026
  • Review time: 194 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

ColActive Plus is indicated for use in adult patients for the management of full and partial thickness wounds including: • Pressure ulcers, • Diabetic ulcers, • Ulcers caused by mixed vascular etiologies, • Venous ulcers, • Surgical wounds, • Abrasions and lacerations, • Traumatic wounds, and • Partial thickness burns.

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Other KGN Clearances

The newest 510(k)s for the same product code; their median review was 217 days; see every KGN device

Record

Type
Traditional
Received
Feb 27, 2026
Review panel
Unknown

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.